Beyond oncology, ANGPTL4 has also been implicated in STAT3 regulation in polycystic ovary syndrome and diabetes [51, 52], indicating its broader role in modulating JAK/STAT3 signaling across diseases. This evidence concerns the gene STAT3 and diabetes mellitus.